Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects
-
Published:2024-09
Issue:
Volume:275
Page:116534
-
ISSN:0223-5234
-
Container-title:European Journal of Medicinal Chemistry
-
language:en
-
Short-container-title:European Journal of Medicinal Chemistry
Author:
Lu Yunlong,
Liang Zhenlin,
Liu Lijuan,
Zhou Yanyu,
Liu Chao,
Zhao Zhihao,
Zheng Tianpeng,
Du Qianming,
Liu WukunORCID